Go-sha-jinki-Gan (GJG) ameliorates allodynia in chronic constriction injury model mice via suppression of TNF-{alpha} expression in the spinal cord

Conclusions Our data suggest that GJG ameliorates allodynia in chronic constriction injury model mice via suppression of tumor necrosis factor-α expression derived from activated microglia. GJG is a promising drug for the treatment of neuropathic pain induced by neuro-inflammation.

http://mpx.sagepub.com/cgi/content/abstract/12/0/1744806916656382?rss=1

Source: Molecular Pain - June 12, 2016 Category: Molecular Biology Authors: Nakanishi, M., Nakae, A., Kishida, Y., Baba, K., Sakashita, N., Shibata, M., Yoshikawa, H., Hagihara, K. Tags: Research Article Source Type: research